Jules Evans is the Director of the Challenging Psychedelic Experiences Project and the lead author and editor of the Substack newsletter Ecstatic Integration. Kristin Nash is the executive director of the William G. Nash Foundation which focuses on harm reduction and psychedelic safety, and is involved with an important initiative to improve public communication on psychedelics as part of the new California psychedelic bill. The two join me on the podcast for an exploratory conversation on how to communicate the risks of psychedelic drugs. We talk about the variety and likelihood of adverse psychedelic experiences, the recent case of a pilot who tried to crash a plane while on mushrooms, whether it’s possible to truly consent to the psychospiritual changes brought on by some drugs, and the dangers of messaging psychedelics as a mental health treatment. We conclude by painting a picture of what we would want public health messaging around these drugs to be to reduce negative experiences and ensure those most at risk avoid them.

You can find the podcast on Apple Podcasts, Spotify, and YouTube.

Links:

* Jules Evans, How to Communicate the Risk of Psychedelics

* Jane Hu, 5 Questions for Kristin Nash

* Canadian Psychedelic Survey

* Jules Evans, Extended Difficulties Following the Use of Psychedelic Drugs

* Huberman Lab, Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health

* Tate et al., Trends in Hallucinogen-associated Emergency Department Visits and Hospitalizations in California from 2016–2021

* Andrew Cutler, Eve Theory of Consciousness 3.0

* Clinicaltrials.gov

* Theo Von Describes the Difference Between DMT & Ayahuasca